Virtual Educational Channel

OESO and the OESO-SEMPIRE Platform of Excellence in Esophagology

continue to be a trail blazer

in all fields of Esophagology.


A new model of Education has come forward

with the OESO-SEMPIRE Virtual Educational Channel.


Indeed, going beyond the traditional series of presentations one after the other,

the clinical case of a patient becomes the focal point of interest: it becomes
the starting point of a two hour intense educational interaction between top experts,

punctuated by comments and questions by a worldwide floor



15th meeting:

From the Pilot Center of Geneva


Department of Visceral Surgery,

Hôpitaux Universitaires de Genève (HUG)


Hosted by Prof. Stefan Paul Mönig,

Head of Upper-GI Surgery


Thursday, December 9, 2021

Europe: CET, Geneva, 5 – 6.30 pm


  • North America: West Coast: 8 – 9.30 am / East Coast: 11 am – 0.30 pm
  • South America: São Paulo, 1 – 2.30 pm
  • Africa: Bomet, Kenya, 7 – 8.30 pm
  • Asia: Beijing, Midnight 12 – 1.30 am (December 10, 2021)
  • Australia: Melbourne, 3 – 4.30 am (December 10, 2021)



(Preliminary presentations)


  • Oligometastatic esophago-gastric cancer:
    is there still a place for surgery? Dr M. Chevallay (Geneva)
  • The OMEC Project. Dr T. Kroese (Utrecht)



Two cases of oligometastatic adenocarcinoma of the esophagus


Presentation of the cases:

Dr Mickael Chevallay (Geneva)










A 59 year old male in excellent condition suffering from epigastric pain and weight loss

for 2 months.


  • Gastroscopy (April 2020): lesion at the distal part of the esophagus
    (35-40 cm from dental arches), developed on Barrett esophagus.
  • Biopsy: adenocarcinoma, HER-2 negative.
  • Staging with thoraco-abdominal PET Scan and echo-endoscopy:
    no metastatic disease.


  • Neoadjuvant treatment (CROSS protocol), May – June 2020.


  • New staging with PET-Scan and Liver MRI: two liver metastases.









A 58 year old male with tobacco use, chronic obstructive pulmonary disease

and sleep apnea. Dysphagia and hematemeses.


  • Gastroscopy (April 2021): lesion at the distal part of the esophagus
    (38-42 cm from dental arches).
  • Echo-endoscopy staging: uT3 N2.
  • Biopsy: adenocarcinoma, HER-2 negative.
  • Staging with thoraco-abdominal PET Scan: 4 liver metastases.


  • Systemic chemotherapy (FLOT protocol), May – June 2021.


  • New staging with PET-Scan and Liver MRI: regression of liver metastases.



Discussion: Management of oligo metastases.



Panel for discussion


Local panel (Geneva):

Stefan Mönig

Minoa Jung

Olivier Huber


International multi-disciplinary panel:

T. Goëtze, Surgical Oncology (Frankfurt, Germany)

T. Schmidt, Surgical Oncology (Köln, Germany)

T.E. Kroese, Surgery (Utrecht, Netherland)

R. Langer, Pathology (Linz, Austria)

J. Wendelmayer, Surgery (Verona, Italy)

S. Schoppmann, Surgery (Vienna, Austria)



Registration is free, but mandatory.


Free registration







In the framework of its cooperation with the New York Academy of Sciences, OESO is pleased to announce to the international scientific community the publication (Wiley Publ.) of the 15th and 16th volumes of its Encyclopedia of Esophagology.


These two books, which follow the 15th OESO World Congress in Beijing, contain 39 Review Articles in two consecutive special issues of the Annals of the New York Academy of Sciences.


These 39 papers, like the congress they follow, cover topics related to the various disciplines represented in OESO, and each of them is the result of the work of teams of international specialists of the highest level in their fields.



These 2 volumes are available on the 2 links provided here below:


multi-disciplinary, updated information of the highest interest.



These two issues of Annals of the New York Academy of Sciences (Volumes 1481 and 1482) further the mission of the OESO (World Organization for Specialized Studies on Diseases of the Esophagus): dissemination of knowledge and the sharing of information in the field of the foregut.


The work of the OESO is in line with the UNESCO Constitution and directed toward state-of-the art clinical evaluations of patients from worldwide teams of experts in the nineteen disciplines represented in its scientific committees.


Since its founding, the OESO has fostered a close relationship with Annals of the New York Academy of Sciences that has resulted in several special issues published over the past decade.

The newly created OESO-Stanford SEMPIRE Platform of Excellence in Esophagology, in cooperation with Stanford Medicine, plans to initiate a multidisciplinary educational program that includes discussions of clinical cases and access to second opinion.


Robert Giuli, MD, FACS

Professor of Surgery

OESO Founder and Deputy Executive Director





OESO Head Office

2, Bd Pershing

75017 Paris, France

Tel. + 33 (0)1 55 37 90 15


Follow us

OESO is now active

on social media!

to get the latest on OESO news, announcements, events, and courses, and to let us know your thoughts!











©2021 OESO – webdesign: